SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals
SEC Accession No. 0001140361-11-058836
Filing Date
2011-12-23
Accepted
2011-12-23 14:10:38
Documents
1
Filing Date Changed
2011-12-23
Group Members
OCCITAN MASTER FUND L.P.

Document Format Files

Seq Description Document Type Size
1 ALEXZA PHARMACEUTICALS INC SC 13G 12-14-2011 formsc13g.htm SC 13G 110331
  Complete submission text file 0001140361-11-058836.txt   111857
Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043 650.944.7000
Alexza Pharmaceuticals Inc. (Subject) CIK: 0001344413 (see all company filings)

IRS No.: 770567768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-82505 | Film No.: 111280042
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 55 NEW BOND STREET 4TH FLOOR LONDON X0 W1S 1DG
Business Address 55 NEW BOND STREET 4TH FLOOR LONDON X0 W1S 1DG 020 7071 3900
Occitan Capital Partners LLP (Filed by) CIK: 0001537866 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G